CAS 118194-13-1

Sojasaponina Ab

Descripción:

Sojasaponina Ab es un saponina triterpenoide derivada de la soja, específicamente de la especie Glycine max. Se caracteriza por su estructura compleja, que incluye un aglicona hidrofóbica y uno o más moieties de azúcar, lo que contribuye a su naturaleza anfifílica. Este compuesto exhibe diversas actividades biológicas, incluyendo propiedades antioxidantes, antiinflamatorias y potenciales anticancerígenas, lo que lo hace de interés tanto en la investigación nutricional como farmacéutica. Sojasaponina Ab es conocido por su capacidad para interactuar con las membranas celulares, lo que puede influir en la permeabilidad de la membrana y las vías de señalización celular. Además, se ha estudiado por su papel en la mejora de la biodisponibilidad de ciertos nutrientes y sus posibles efectos en la salud intestinal. El compuesto se extrae típicamente de semillas de soja y puede ser analizado utilizando técnicas como la cromatografía líquida de alta resolución (HPLC) para la evaluación de pureza y concentración. Su perfil de seguridad y eficacia en diversas aplicaciones sigue siendo objeto de investigación continua, particularmente en el contexto de alimentos funcionales y suplementos dietéticos.

Fórmula: C₆₇H₁₀₄O₃₃

InChI: InChI=1S/C67H104O33/c1-26(71)87-24-35-48(89-27(2)72)52(90-28(3)73)53(91-29(4)74)61(94-35)96-47-32(75)23-88-57(46(47)83)100-55-54(84)62(5,6)20-31-30-12-13-37-64(8)16-15-38(65(9,25-70)36(64)14-17-67(37,11)66(30,10)19-18-63(31,55)7)95-60-51(44(81)43(80)49(97-60)56(85)86)99-59-50(42(79)40(77)34(22-69)93-59)98-58-45(82)41(78)39(76)33(21-68)92-58/h12,31-55,57-61,68-70,75-84H,13-25H2,1-11H3,(H,85,86)/t31-,32-,33+,34+,35+,36+,37+,38-,39+,40-,41-,42-,43-,44-,45+,46+,47-,48+,49-,50+,51+,52-,53+,54-,55+,57-,58-,59-,60+,61-,63+,64-,65+,66+,67+/m0/s1

Clave InChI: InChIKey=YZNCIXVBVQRGQN-YUTHWCJWSA-N

SMILES: C[C@]12[C@@]3(C)C([C@]4([C@@](C)(CC3)[C@H](O[C@H]5[C@H](O)[C@@H](O[C@H]6[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O6)[C@@H](O)CO5)[C@H](O)C(C)(C)C4)[H])=CC[C@@]1([C@]7(C)[C@@](CC2)([C@](CO)(C)[C@@H](O[C@H]8[C@H](O[C@H]9[C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10O)[C@@H](O)[C@@H](O)[C@@H](CO)O9)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O8)CC7)[H])[H]

Sinónimos:

• (3β,4β,21β,22β)-21,23-Dihydroxy-22-[[3-O-(2,3,4,6-tetra-O-acetyl-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl)-α-<smallcap>L</smallcap>-arabinopyranosyl]oxy]olean-12-en-3-yl O-β-<smallcap>D</smallcap>-glucopyranosyl-(1→2)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→2)-β-<smallcap>D</span>-glucopyranosiduronic acid
• Soyasaponin Ab
• SoyasaponinAb
• β-<span class="text-smallcaps">D</smallcap>-Glucopyranosiduronic acid, (3β,4β,21β,22β)-21,23-dihydroxy-22-[[3-O-(2,3,4,6-tetra-O-acetyl-β-<smallcap>D</smallcap>-glucopyranosyl)-α-<smallcap>L</smallcap>-arabinopyranosyl]oxy]olean-12-en-3-yl O-β-<smallcap>D</smallcap>-glucopyranosyl-(1→2)-O-β-<smallcap>D</span>-galactopyranosyl-(1→2)-
• Acetylsoyasaponin A1
• (3β,4β,21β,22β)-21,23-Dihydroxy-22-[[3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-α-L-arabinopyranosyl]oxy]olean-12-en-3-yl O-β-D-glucopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→2)-β-D-glucopyranosiduronic acid
• β-D-Glucopyranosiduronic acid, (3β,4β,21β,22β)-21,23-dihydroxy-22-[[3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-α-L-arabinopyranosyl]oxy]olean-12-en-3-yl O-β-D-glucopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→2)-
• soyosaponin Ab

Soyasaponin Ab

CAS: 118194-13-1

Fórmula: C₆₇H₁₀₄O₃₃

Peso molecular: 1437.54

Ref: 7W-GY0758

Soyasaponin Ab

CAS: 118194-13-1

Soyasaponin Ab

Pureza: ≥98%

Peso molecular: 1437.52g/mol

Ref: 54-BUP20150

Soyasaponin Ab

CAS: 118194-13-1

Soyasaponin Ab may represent a viable candidate for effective vaccine adjuvant, TLR4 receptor dependent pathway may be involved in immune stimulatory effects of soyasaponin Ab. Soyasaponin Ab has anti-inflammatory effects, it can inhibit colon shortening, myeloperoxidase activity, the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), and activation of the transcription factor nuclear factor-κB (NF-κB); soyasaponin Ab (1, 2, 5, and 10 μM) can inhibit the production of NO (IC50 = 1.6 ± 0.1 uM) and prosta. Soyasaponin Aa and Ab can markedly inhibit adipocyte differentiation and expression of various adipogenic marker genes through the downregulation of the adipogenesis-related transcription factors PPARγ and C/EBPα in 3T3-L1 adipocytes. They also can prevent scopolamine-induced memory impairment in mice without the inhibition of acetylcholinesterase, exhibit memory-enhancing effects.

Fórmula: C₆₇H₁₀₄O₃₃

Pureza: 95%~99%

Forma y color: Powder

Peso molecular: 1437.54

Ref: BP-BP1735

Soyasaponin Ab

CAS: 118194-13-1

Soyasaponin Ab: a potential vaccine adjuvant via TLR4 pathway.

Fórmula: C₆₇H₁₀₄O₃₃

Pureza: 98.27% - 99.79%

Forma y color: Solid

Peso molecular: 1437.52

Ref: TM-TN2232

Soyasaponin Ab

CAS: 118194-13-1

Soyasaponin Ab is a natural product that has immunomodulatory effects on the immune system. It inhibits the production of TNF-α, which is an inflammatory cytokine. Soyasaponin Ab also has anti-inflammatory properties and can be used to treat bowel disease. The mechanism of action is not clear, but it may be due to inhibition of fatty acid synthesis in the liver or stimulation of antioxidative enzymes. This compound is structurally similar to nonsteroidal anti-inflammatory drugs (NSAIDs). Soyasaponin Ab has been shown to inhibit LPS-induced inflammatory response and reduce metabolic disorders in vitro.

Pureza: Min. 98 Area-%

Forma y color: Powder

Ref: 3D-FS74366